Medinotec Inc. Files Q3 2024 10-Q

TL;DR

Medinotec Inc. 10-Q filed for Q3 2024, ending Nov 30.

AI Summary

Medinotec Inc. filed its 10-Q for the period ending November 30, 2024. The company, incorporated in Nevada and operating in the Surgical & Medical Instruments & Apparatus sector, is based in Dubai. The filing covers the third quarter of their fiscal year, which ends on February 28th.

Why It Matters

This filing provides investors with an update on Medinotec Inc.'s financial performance and operational status for the third quarter of fiscal year 2024.

Risk Assessment

Risk Level: low — This is a standard quarterly financial filing with no immediate red flags or significant new information presented in the provided snippet.

Key Players & Entities

• Medinotec Inc. (company) — Filer of the 10-Q
• November 30, 2024 (date) — End of the reporting period
• February 28 (date) — Fiscal year end
• 3841 (other) — Standard Industrial Classification for Surgical & Medical Instruments & Apparatus
• NV (state) — State of Incorporation

FAQ

Key Financial Figures

• $3 million — lity of a private placement of at least $3 million. This acquisition formed the "Medinotec
• $1.235 billion — s: its total annual gross revenues are $1.235 billion or more; it has issued more than $1 b
• $1 billion — lion or more; it has issued more than $1 billion in non-convertible debt in the past thr

Filing Documents

• mdnc10q3_113024.htm (10-Q) — 889KB
• image_001.jpg (GRAPHIC) — 4KB
• ex31_1.htm (EX-31) — 9KB
• ex31_2.htm (EX-31.2) — 9KB
• ex32_1.htm (EX-32.1) — 5KB
• 0001663577-25-000018.txt ( ) — 4556KB
• mdnc-20241130.xsd (EX-101.SCH) — 29KB
• mdnc-20241130_cal.xml (EX-101.CAL) — 45KB
• mdnc-20241130_def.xml (EX-101.DEF) — 86KB
• mdnc-20241130_lab.xml (EX-101.LAB) — 207KB
• mdnc-20241130_pre.xml (EX-101.PRE) — 191KB
• mdnc10q3_113024_htm.xml (XML) — 822KB

– FINANCIAL INFORMATION

PART I – FINANCIAL INFORMATION Item 1: Consolidated Financial Statements (unaudited for period ended November 30, 2024) 3 Item 2:

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 4 Item 3:

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 17 Item 4:

Controls and Procedures

Controls and Procedures 17

– OTHER INFORMATION

PART II – OTHER INFORMATION Item 1:

Legal Proceedings

Legal Proceedings 18 Item 1A:

Risk Factors

Risk Factors 18 Item 2: Unregistered Sales of Equity Securities and Use of Proceeds 18 Item 3: Defaults Upon Senior Securities 18 Item 4: Mine Safety Disclosure 18 Item 5: Other Information 18 Item 6: Exhibits 18 2 Table of Contents

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION

Consolidated Financial Statements

Item 1. Consolidated Financial Statements Our unaudited consolidated financial statements included in this Form 10-Q are as follows: Page Number 2 Unaudited Consolidated Balance Sheets as of November 30, 2024 and February 29, 2024; 3 Unaudited Consolidated Statements of Operations and Comprehensive Income/(Loss) for the three and nine months ended November 30, 2024 and November 30, 2023; 4 Unaudited Consolidated Statements of Stockholders' Equity / (Deficit) for the three and nine months ended November 30, 2024 and November 30, 2023; 5 Unaudited Consolidated Statements of Cash Flows for the nine months ended November 30, 2024 and November 30, 2023; and 6 Notes to the Unaudited Consolidated Financial Statements. 3 Table of Contents Medinotec Inc. Consolidated Financial Statements Consolidated Balance Sheets (Unaudited) November 30, 2024 $ February 29, 2024 $ Assets Current Assets Cash 2,676,525 2,808,910 Accounts receivable, net of allowances 992,464 589,761 Inventory 1,151,466 863,452 Other current assets 99,859 117,174 Total Current Assets 4,920,314 4,379,297 Property, plant and equipment, net of accumulated depreciation 378,294 320,122 Deferred tax asset 18,575 42,881 Operating right-of-use asset 45,438 61,979 Total Assets 5,362,621 4,804,279 Liabilities and Stockholders' Equity Current Liabilities Accounts payable and accrued liabilities 1,446,751 801,550 Due to stockholders/directors — 1,587 Operating lease liability, current portion 28,217 24,316 Total Current Liabilities 1,474,968 827,453 Long Term Liabilities Related party loans payable 1,041,090 1,769,957 Operating lease liability, net of current portion 20,731 39,698 Total Liabilities 2,536,789 2,637,108 Stockholders' Equity Capital stock $ .001 par value; shares authorized 200,000,000 ; 11,733,750 shares issued and outstanding 11,734 11,734 Capital stock additional paid in capital 3,

View Full Filing

View this 10-Q filing on SEC EDGAR